Scheltens P - Search Results

1

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design.

de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, Batrla-Utermann R, Scheltens P, Teunissen CE, van Berckel BN, van der Flier WM. de Wilde A, et al. Among authors: scheltens p. Alzheimers Dement (Amst). 2017 Jan 23;6:143-151. doi: 10.1016/j.dadm.2017.01.003. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28239639 Free PMC article.

2

Imaging of white matter lesions.

Barkhof F, Scheltens P. Barkhof F, et al. Among authors: scheltens p. Cerebrovasc Dis. 2002;13 Suppl 2:21-30. doi: 10.1159/000049146. Cerebrovasc Dis. 2002. PMID: 11901239 Review.

3

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.

Scheltens P, Fox N, Barkhof F, De Carli C. Scheltens P, et al. Lancet Neurol. 2002 May;1(1):13-21. doi: 10.1016/s1474-4422(02)00002-9. Lancet Neurol. 2002. PMID: 12849541 Review.

4

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC. Rosso SM, et al. Among authors: scheltens p. Arch Neurol. 2003 Sep;60(9):1209-13. doi: 10.1001/archneur.60.9.1209. Arch Neurol. 2003. PMID: 12975285

5

Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.

Bastos Leite AJ, van Straaten EC, Scheltens P, Lycklama G, Barkhof F. Bastos Leite AJ, et al. Among authors: scheltens p. Stroke. 2004 Feb;35(2):415-9. doi: 10.1161/01.STR.0000109226.67085.5A. Epub 2004 Jan 15. Stroke. 2004. PMID: 14726554

6

White matter lesions and hippocampal atrophy in Alzheimer's disease.

de Leeuw FE, Barkhof F, Scheltens P. de Leeuw FE, et al. Among authors: scheltens p. Neurology. 2004 Jan 27;62(2):310-2. doi: 10.1212/01.wnl.0000103289.03648.ad. Neurology. 2004. PMID: 14745078

7

Biomarkers for Alzheimer's disease. Which way to go?

Teunissen CE, Scheltens P. Teunissen CE, et al. Among authors: scheltens p. Neurobiol Aging. 2004 Jul;25(6):695-6. doi: 10.1016/j.neurobiolaging.2003.08.013. Neurobiol Aging. 2004. PMID: 15165690 No abstract available.

8

An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis.

Lazeron RH, Rombouts SA, Scheltens P, Polman CH, Barkhof F. Lazeron RH, et al. Among authors: scheltens p. Mult Scler. 2004 Oct;10(5):549-55. doi: 10.1191/1352458504ms1072oa. Mult Scler. 2004. PMID: 15471372

9

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA. Schoonenboom NS, et al. Among authors: scheltens p. Clin Chem. 2005 Jan;51(1):189-95. doi: 10.1373/clinchem.2004.039735. Epub 2004 Nov 11. Clin Chem. 2005. PMID: 15539465

10

Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.

Goekoop R, Rombouts SA, Jonker C, Hibbel A, Knol DL, Truyen L, Barkhof F, Scheltens P. Goekoop R, et al. Among authors: scheltens p. Neuroimage. 2004 Dec;23(4):1450-9. doi: 10.1016/j.neuroimage.2004.08.006. Neuroimage. 2004. PMID: 15589109 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,272 results

Search Page

Filters